Sunday, 25 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Company
Drug
Genmab’s Tivdak Approved in Japan for Advanced Cervical Cancer Treatment
March 28, 2025
Company
CStone Pharmaceuticals Reports 2024 Results with License Fee Growth Offsetting Drug Sales Decline
March 28, 2025
Company
Deals
TransThera and Akeso Biopharma Collaborate on HCC Study with Tinengotinib and Bispecific Antibodies
March 28, 2025
Company
Drug
NMPA Approves Qingfeng’s Suraxavir Marboxil for Influenza A and B Treatment
March 28, 2025
Company
Medtronic Launches Digital Innovation Base in Beijing’s BioPark
March 28, 2025
Company
Drug
Huadong Medicine Gains NMPA Approval for HDM3019 Rheumatoid Arthritis Trial
March 28, 2025
Company
Lee’s Pharmaceutical Holdings Ltd Reports 32.9% Revenue Growth in 2023
March 28, 2025
Company
RemeGen’s 2024 Revenue Soars 58.54% on Strong Product Sales and R&D Growth
March 28, 2025
Company
JW Therapeutics Sees 9% Revenue Decline in 2024 Amid Commercial Strategy Shift
March 28, 2025
Company
Ascentage Pharma’s Revenue Soars 342% in 2024 on Strong Drug Sales and Partnerships
March 28, 2025
Company
Shanghai Pharmaceuticals Reports 5.75% Revenue Growth in 2024 with Innovation Initiatives
March 28, 2025
Company
Drug
YiChang HEC’s Yiqibuvir Approved by NMPA for Chronic HCV Infection
March 28, 2025
1
2
3
4
5
6
…
31
32
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
